泰立沙Tykerb资料拉帕替尼lapatinib资料相关指南、规范与共识、关键临床研究 回顾.pptVIP

　Tykerb?　Tyrosine+kinase+erbB1B2 指南、规范与共识 Tykerb? (lapatinib) capecitabine (2nd line) trastuzumab (2nd line) HER2阳性晚期/复发转移性乳腺癌，曲妥珠单抗治疗疾病进展后 CACA, CBCS, 2011 Tykerb? (lapatinib) capecitabine (2nd line) trastuzumab (2nd line) HER2阳性乳腺癌曲妥珠单抗治疗出现疾病进展后 CACA, CBCS, 2012 Tykerb? (lapatinib) trastuzumab (2nd line) Systemic Treatment of Recurrent or Stage IV Disease ER and PR Negative; or ER and/or PR Positive and Endocrine Refractory; and HER2 Positive NCCN V2.2013 Tykerb? (lapatinib) capecitabine (2nd line) trastuzumab (2nd line) Chemotherapy Regimens for Recurrent or Met